Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

International Phase III, Multi Center, Randomized, Double Blind, Placebo and Active Controlled and Parallel Group Clinical Trial to Evaluate the Efficacy and Safety of Oral Minoxidil 1 mg in Female Patients With Androgenetic Alopecia

NCT05888922 is registered in ClinicalTrials.gov with Industrial Farmacéutica Cantabria, S.A. as lead sponsor.

NCT NCT05888922
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05888922 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
International Phase III, Multi Center, Randomized, Double Blind, Placebo and Active Controlled and Parallel Group Clinical Trial to Evaluate the Efficacy and Safety of Oral Minoxidil 1 mg in Female Patients With Androgenetic Alopecia
Lead sponsor
Industrial Farmacéutica Cantabria, S.A.
Phase
Phase 3
Overall status
Active, not recruiting
Start date
October 17, 2024
Completion date
November 16, 2026
Enrollment
520 (estimated)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

androgenetic alopecia, female pattern baldness